Dr. Deborah Birx has been tapped to help manage the distribution of remdesivir to hospitals nationwide, the White House said Friday, amid growing frustration among physicians who say they have been unable to access the drug for their sickest COVID-19 patients.Full coverage of the coronavirus outbreakBirx — a key member of the White House’s coronavirus task force — is the person “who’s constantly reviewing the numbers, constantly reviewing the data,” White House press secretary Kayleigh McEnany said during a briefing Friday. “She really has the best grasp as to how that should be distributed, so she will be one of the chief consultants.”A week ago, the Food and Drug Administration issued an emergency use authorization for remdesivir after preliminary evidence found the drug cut the time patients had to spend in the hospital from 15 days, on average, to 11.The FDA’s authorization specified the unapproved drug could be used for severely ill adults and children hospitalized with suspected or confirmed COVID-19 diagnoses who have low blood oxygen levels or who are on a ventilator.The move was intended to increase physicians’ access to remdesivir, which is not a cure, but is the only treatment so far to have shown a moderate


Continue To Full Article